{"summary": "a novel purification strategy for the two main type I ribosome-inactivating proteins (RIPs), -MMC and MAP30, was successfully developed for laboratory-scale preparation. two polyethylene glycol (PEG)ylated proteins were synthesized and purified. both proteins showed about 60%\u201370% antitumor and antivirus activities. PEGylated RIPs can be constructed with nanomaterials to be a targeting drug that can further decrease immunogenicity and side effects. they can be constructed with nanomaterials to be a targeting drug that can further decrease immunogenicity and side effects. fda has approved the PEGylated forms of therapeutic proteins. uricase, erythropoietin, granulocyte-colony stimulating factor, interferon, adenosine deaminase, asparaginase, and a growth hormone antagonist. nanotechnology uses nanomaterials to pack potential therapeutic proteins. materials and methods Materials Bitter melon seeds were obtained from the Institute of Agricultural Science and Technique of Sichuan Province, China. Matrices for electrophoresis were products of Sigma-Aldrich (St Louis, MO) and Bio-Rad Laboratories (Hercules, CA) a linear gradient of 0\u20130.15 M NaCl in pH 7.0, 20 mM sodium phosphate buffer eluted the column and two peaks with 30 kDa proteins were respectively collected. identification of -MMC and MAP30 SDS-PAGE SDS-PAGE was performed according to Laemmli. a total of 3 104 cells/mL were applied into 96-well microtiter plates at 100 L per well and exposed to PEGylated -MMC, PEGylated MAP30, and un-PEGylated counterparts. each concentration was tested in quadruplicate. the optical density (OD) at 570 nm was measured using an ELISA plate reader. cell viability and proliferation were observed together with controls. the inhibitory effect of PEGylated RIPs on herpes simplex virus-1 VERO cells were cultured to logarithmic growth phase. 105 VERO cells/mL was applied to 96-well microtiter plates at 100 L per well. exposed to un-PEGylated proteins at 3.3 mol L13.3 nmol L1 (100 mg L10.1 mg L1) and acyclovir (ACV) at 10 mol L10.01 mol L1 for 48 hours. each concentration was tested in quadruplicate. the percentage of inhibition was calculated by the formula described under the heading \"Measurement of cytotoxicity\" Sprague Dawley rats were randomly classified into control, -MMC, PEGylated -MMC, MAP30, and PEGylated MAP30 groups of ten each. the reactions were allowed to develop at 37\u00b0C for 15 minutes. tetramethyl benzidine (Sigma-Aldrich) was added as a substrate for horseradish peroxidase. purification of -MMC and MAP30 All steps tried either alone or in combination within the process of purification were carried out at 4\u20136\u00b0C unless specifically stated. -MMC and MAP30 SDS-PAGE SDS-PAGE SDS-PAGE were performed according to Laemmli. Western blotting analysis Briefly, -MMC was separated on SDS-PAGE and then transferred to an NC membrane. nonspecific binding was blocked and washed by placing the membrane in a solution of BSA. a total of 3 104 cells/mL were applied into 96-well microtiter plates at 100 L per well and exposed to PEGylated -MMC, PEGylated MAP30, and un-PEGylated counterparts. each concentration was tested in quadruplicate. at 570 nm was measured using an ELISA plate reader (EL 800, BIO-TEK, Atlanta, GA) cell viability and proliferation were observed together with controls. the inhibitory effect of PEGylated RIPs on herpes simplex virus-1 VERO cells was observed. microtiter plates were exposed to un-PEGylated proteins and PEGylated-proteins at 3.3 mol L13.3 nmol L1 (100 mg L10.1 mg L1) and acyclovir (ACV) at 10 mol L10.01 mol L1 for 48 hours. each concentration was tested in quadruplicate. 100 L of infected supernatant, which was 101 to 1010 diluted with medium, was added to each well. 100 L of infected supernatant, which was 101 to 1010 diluted with medium, was added to each well. VERO cells/mL were seeded into 24-well plates at 1 mL/well. then incubated with 5% CO2 at 37\u00b0C for 24 hours. 100 L of culture medium containing proteins was added to each well. negative and positive cell control established. 96-well plates were coated with 100 L of 30 g/mL purified antigen (RIPs and PEG-RIPs) in 0.05 M carbonate-coating buffer, pH 9.6, and incubated at 4\u00b0C. after washing, 300 L of PBS containing 3% BSA, pH 7.4, was added to each well. both -MMC and MAP30 were assessed by SDS-PAGE and Western blotting. the theoretical pI of -MMC is 9.32 and MAP30 is 8.86. ESI-QUAD-MS was used to further identify the two proteins. summarization of purification of alpha-momorcharin (-MMC) and momordica anti-HIV protein (MAP30) from 200 g of bitter melon seeds Steps Total volume (mL) Protein content (mg/mL) Total protein (mg) Field (%) Extract-free cells 800 15.0 12,000 100 AS precipitation 100 37.5 3750 32.0 SP Sepharose FF 360 2.3 828 6.9 Sephacryl S-100 110 4.5 495 the average MW of -MMC was 28551.6 Da (B) MALDI-TOF-MS profile of MAP30. the average MW of MAP30 was 29072.0 Da. the (mPEG)2-Lys-NHS was around 20 kDa and the PEG conjugates were observed at 49899.4 Da, 70430.9 Da and 91057.6 Da. all of the experiments cleaved the supercoiled double-stranded DNA to produce nicked circular or linear DNA. JAR cells were seeded on 96-well plates and were treated with increasing concentrations of PEGylated RIPs and un-PEGylated counterparts for 72 hours. the concentrations of 1.5, 0.3, and 0.06 mg/mL started to significantly reduce the proliferation of cells after 48 and 72 hours of incubation. -MMC-treated groups showed fewer cells and abnormal shapes. MAP30 and PEGylated MAP30 also showed a similar cytotoxic effect to JAR cells. dose range of tested proteins inhibiting VERO cell infection with virus was below 3.3 mol L1. IC50 was 0.67 mol L1 with -MMC, 2.94 mol L1 with PEG--MMC, 0.47 mol L1 with MAP30, 2.39 mol L1 with PEG-MAP30, and 3.55 mol L1 with ACV. the extent of cytopathy was gradually reduced with the increase of the protein concentration. most cells did not appear cytopathic caused by virus at a concentration of 3.3 mol L1. this indicated that proteins played an important role in the inhibition on HSV-1. positive control mol L1,* 0.923 0.008 0 Negative control 0.004 0.001 -MMC 3.3 0.270 0.011 71.055 0.67 0.3 0.550 0.009 40.588 0.03 0.827 0.003 10.446 0.003 0.892 0.004 3.373 -MMC-PEG 3.3 0.452 0.004 51.270 2.94 0.3 0.689 0.004 25.508 0.03 0.866 0.004 6.2 the results showed that the PEGylated RIPs allowed to some extent decrease of immunogenicity while compared with un-PEGylated counterparts. the decrease of IgG generation was approximately 70% for PEGylated -MMC compared with the un-PEGylated counterpart. MALDI-TOF-MS was used to determine the accurate molecular weight of -MMC and MAP30. the molecular weights were 28551.6 Da and 29072.0 Da respectively. the theoretical molecular weight was 27368.36 Da and 29600.74 Da. the average MW of -MMC was 28551.6 Da (B) MALDI-TOF-MS profile of MAP30. the average MW of MAP30 was 29072.0 Da. one-mer and two-mer PEGylated isomers with 50335.6 Da and 70614.2 Da were found from MAP30-PEG conjugates. MALDI-TOF-MS analysis of both PEGylated -MMC and PEGylated MAP30 conjugates. supercoiled DNA (pUC18) was incubated with PEGylated RIPs and un-PEGylated counterparts. all of the experiments cleaved the supercoiled double-stranded DNA to produce nicked circular or linear DNA. all of them exhibited DNase-like activity. -MMC/MAP30 and PEGylated MAP30 induced alterations in the morphology of choriocarcinoma JAR cells. after processing for 72 hours, untreated JAR cells extended and flattened. fewer cells and abnormal shapes such as shrinkage, blebbing, and loss of membrane asymmetry. measure of cytotoxicity was designed to establish appropriate dose range for the research of inhibitory effect of proteins on HSV-1 to VERO cells. -MMC/MAP30, PEG--MMC/MAP30, and ACV had no significant inhibition on VERO cells in the tested concentration range. the ratio of cell viability with MAP30 was higher than -MMC and PEG-MAP30 was higher than PEG--MMC. at the same dose, the ratio of cell viability with MAP30 was higher than -MMC and PEG-MAP30 was higher than PEG--MMC. VERO cells infected with HSV-1 after 48 hours displayed alterations in the morphology. inhibitory effects of RIPs and PEGylated RIPs on herpes simplex virus-1 antigen Protein Concentration OD450 of HSV-1 antigen (%) 50% inhibiting concentration (mol1) Positive control mol L1,* 0.923 0.008 0 Negative control 0.004 0.001 -MMC 3.3 0.270 0.011 71.055 0.67 0.3 0.550 0.009 40.588 0.03 0.827 0.003 10.446 0.003 0.354 0.004 61.901 2.39 1 0.597 0.006 35.450 0.1 0.872 0.003 5.515 0.01 0.921 0.006 0.254. -MMC, alpha-momorcharin; MAP30, momordica anti-HIV protein; PEG, polyethylene glycol. mMC modifier possessed one-mer, two-mer, and three-mer PEG-bound chains. MAP30 modifier obtained one-mer and two-mer PEG-bound chains. both PEGylated proteins showed about 60%\u201370% antitumor and antivirus activities."}